Table 1.

Characteristics of included studies.

StudyDesign; country; settingPatients (M/F)Age*MatchingMalocclusion characteristicsBreathing/airways characteristicsExtractionAppliance; anchorageCBCT voxel size
Chen 2018 [49]rNRS; Uni; CHNEX: 25 (10/15)
NEX: 25 (10/15)
EX: 12.2 (NR)
NEX: 12.4 (NR)
-Dental Cl. I; no-mild crowding; ANB 0-4°; average angle/growth type; 1s-SN > 110°; 1i-ML > 99°No snoring/obstructive sleep apnea/adenoid-/tonsillectomy; normal BMI4 × 1st PMsFA; headgearNR
Feizi 2021 [51]rNRS; Pract; USAEX: 9 (4/5)
NEX: 18 (8/10)
EX: 19.2 (11.0–46.0)
NEX: 13.1 (11.0–17.0)
-Dental Class II (≥ 1/2 cusp); no agenesis (excluding M2/M3); no craniofacial anomaly-4x PMsFA0.3 mm
Guo 2022 [53]rNRS; Uni; CHNEX: 120 (0/120)
NEX: 40 (0/40)
EX: 25.1 (20.0–25.0)
NEX: 26.4 (20.0–25.0)
Age; skeletal typeSkeletal Class I-II/1 (ANB > 0°, SN-ML > 28°); no Cl. II/2; mild-moderate crowdingBMI < 27 kg/m2; no breathing disorder4 × 1st PMsFA; MX anterior retraction
≥3 mm
0.3 mm
Joy 2020 [50]rNRS; Uni; USAEX: 41 (20/21)
NEX: 42 (22/20)
EX: 26.1 (18.0-NR)
NEX: 26.0 (18.0-NR)
Age; sexCl. I-III; any crowding-2x MX or 4x PMsFA/AL;0.3 mm
Leslie 2014 [47]rNRS; Uni; USAEX: 64 (23/41)
NEX: 90 (42/48)
EX/NEX: NR (NR-18.0)---4x PMsFA0.4 mm
Mladenovic 2024coll [54, 55]rNRS; Pract; AUSEX: 54 (18/36)
NEX: 59 (24/35)
EX/NEX: 15.0 (NR)CrowdingSkeletal Cl. I-II; any crowding; no craniofacial deformities-2x MX or 4 × 2nd PMsFA0.3 mm
Mostanghi 2021 [52]rNRS; Pract; USAEX: 20 (7/13)
NEX: 20 (5/15)
EX: 24.9 (18.5–38.3)
NEX: 26.2 (16.0–42.6)
Age; sex; treatment durationCrowding or bimaxillary dentoalveolar protrusion; no impactionsNo reported obstructive sleep apnea2x MX or 4x PMsFA0.3 mm
Pliska 2016 [48]rNRS; Uni; USAEX: 26 (8/18)
NEX: 48 (17/31)
EX: 27.4 (18.0-NR)
NEX: 31.9 (18.0-NR)
-Cl. I-II (ANB ≥ 0°); no agenesis-≥2x PMsFANR
Shannon 2012 [45]rNRS; Pract; USAEX: 27 (11/16)
NEX: 61 (30/31)
EX: 13.5 (9.0–22.0)
NEX: 13.2 (10.0–22.0)
-No agenesis; no craniofacial anomaly-4x PMsFANR
Stefanovic 2023 [46]rNRS; Uni; USAEX: 31 (15/16)
NEX: 31 (15/16)
EX: 13.0 (NR)
NEX: 12.9 (NR)
Age; sexCl. I-IIINo breathing disorder4 × 1st PMsFA0.38 mm
Valiathan 2010 [44]rNRS; Uni; USAEX: 20 (10/10)
NEX: 20 (10/10)
EX: 13.6 (11.3–15.6)
NEX: 13.7 (11.3–15.6)
Age,
gender, height, ethnicity, weight, BMI, and
skeletal features, and oropharynx volume
Cl. I; no craniofacial deformitiesNo pharyngeal
pathology and/or nasal obstruction, snoring, obstructive sleep apnea, adenoid- or tonsillectomy.
4x PMsFA0.38 mm
StudyDesign; country; settingPatients (M/F)Age*MatchingMalocclusion characteristicsBreathing/airways characteristicsExtractionAppliance; anchorageCBCT voxel size
Chen 2018 [49]rNRS; Uni; CHNEX: 25 (10/15)
NEX: 25 (10/15)
EX: 12.2 (NR)
NEX: 12.4 (NR)
-Dental Cl. I; no-mild crowding; ANB 0-4°; average angle/growth type; 1s-SN > 110°; 1i-ML > 99°No snoring/obstructive sleep apnea/adenoid-/tonsillectomy; normal BMI4 × 1st PMsFA; headgearNR
Feizi 2021 [51]rNRS; Pract; USAEX: 9 (4/5)
NEX: 18 (8/10)
EX: 19.2 (11.0–46.0)
NEX: 13.1 (11.0–17.0)
-Dental Class II (≥ 1/2 cusp); no agenesis (excluding M2/M3); no craniofacial anomaly-4x PMsFA0.3 mm
Guo 2022 [53]rNRS; Uni; CHNEX: 120 (0/120)
NEX: 40 (0/40)
EX: 25.1 (20.0–25.0)
NEX: 26.4 (20.0–25.0)
Age; skeletal typeSkeletal Class I-II/1 (ANB > 0°, SN-ML > 28°); no Cl. II/2; mild-moderate crowdingBMI < 27 kg/m2; no breathing disorder4 × 1st PMsFA; MX anterior retraction
≥3 mm
0.3 mm
Joy 2020 [50]rNRS; Uni; USAEX: 41 (20/21)
NEX: 42 (22/20)
EX: 26.1 (18.0-NR)
NEX: 26.0 (18.0-NR)
Age; sexCl. I-III; any crowding-2x MX or 4x PMsFA/AL;0.3 mm
Leslie 2014 [47]rNRS; Uni; USAEX: 64 (23/41)
NEX: 90 (42/48)
EX/NEX: NR (NR-18.0)---4x PMsFA0.4 mm
Mladenovic 2024coll [54, 55]rNRS; Pract; AUSEX: 54 (18/36)
NEX: 59 (24/35)
EX/NEX: 15.0 (NR)CrowdingSkeletal Cl. I-II; any crowding; no craniofacial deformities-2x MX or 4 × 2nd PMsFA0.3 mm
Mostanghi 2021 [52]rNRS; Pract; USAEX: 20 (7/13)
NEX: 20 (5/15)
EX: 24.9 (18.5–38.3)
NEX: 26.2 (16.0–42.6)
Age; sex; treatment durationCrowding or bimaxillary dentoalveolar protrusion; no impactionsNo reported obstructive sleep apnea2x MX or 4x PMsFA0.3 mm
Pliska 2016 [48]rNRS; Uni; USAEX: 26 (8/18)
NEX: 48 (17/31)
EX: 27.4 (18.0-NR)
NEX: 31.9 (18.0-NR)
-Cl. I-II (ANB ≥ 0°); no agenesis-≥2x PMsFANR
Shannon 2012 [45]rNRS; Pract; USAEX: 27 (11/16)
NEX: 61 (30/31)
EX: 13.5 (9.0–22.0)
NEX: 13.2 (10.0–22.0)
-No agenesis; no craniofacial anomaly-4x PMsFANR
Stefanovic 2023 [46]rNRS; Uni; USAEX: 31 (15/16)
NEX: 31 (15/16)
EX: 13.0 (NR)
NEX: 12.9 (NR)
Age; sexCl. I-IIINo breathing disorder4 × 1st PMsFA0.38 mm
Valiathan 2010 [44]rNRS; Uni; USAEX: 20 (10/10)
NEX: 20 (10/10)
EX: 13.6 (11.3–15.6)
NEX: 13.7 (11.3–15.6)
Age,
gender, height, ethnicity, weight, BMI, and
skeletal features, and oropharynx volume
Cl. I; no craniofacial deformitiesNo pharyngeal
pathology and/or nasal obstruction, snoring, obstructive sleep apnea, adenoid- or tonsillectomy.
4x PMsFA0.38 mm

AL, aligner; BMI, body mass index; CBCT, cone-bean computerized tomography; Cl., Angle’s Class; coll, collated multiple reports; CVM, cervical vertebrae maturation; EX, extraction group; FA, fixed appliance; M2/M3, 2nd/3rd molar; MX, maxillary; NEX, non-extraction group; NR, not reported; PM, premolar; Pract, private practice; rNRS, retrospective non-randomized study.

Table 1.

Characteristics of included studies.

StudyDesign; country; settingPatients (M/F)Age*MatchingMalocclusion characteristicsBreathing/airways characteristicsExtractionAppliance; anchorageCBCT voxel size
Chen 2018 [49]rNRS; Uni; CHNEX: 25 (10/15)
NEX: 25 (10/15)
EX: 12.2 (NR)
NEX: 12.4 (NR)
-Dental Cl. I; no-mild crowding; ANB 0-4°; average angle/growth type; 1s-SN > 110°; 1i-ML > 99°No snoring/obstructive sleep apnea/adenoid-/tonsillectomy; normal BMI4 × 1st PMsFA; headgearNR
Feizi 2021 [51]rNRS; Pract; USAEX: 9 (4/5)
NEX: 18 (8/10)
EX: 19.2 (11.0–46.0)
NEX: 13.1 (11.0–17.0)
-Dental Class II (≥ 1/2 cusp); no agenesis (excluding M2/M3); no craniofacial anomaly-4x PMsFA0.3 mm
Guo 2022 [53]rNRS; Uni; CHNEX: 120 (0/120)
NEX: 40 (0/40)
EX: 25.1 (20.0–25.0)
NEX: 26.4 (20.0–25.0)
Age; skeletal typeSkeletal Class I-II/1 (ANB > 0°, SN-ML > 28°); no Cl. II/2; mild-moderate crowdingBMI < 27 kg/m2; no breathing disorder4 × 1st PMsFA; MX anterior retraction
≥3 mm
0.3 mm
Joy 2020 [50]rNRS; Uni; USAEX: 41 (20/21)
NEX: 42 (22/20)
EX: 26.1 (18.0-NR)
NEX: 26.0 (18.0-NR)
Age; sexCl. I-III; any crowding-2x MX or 4x PMsFA/AL;0.3 mm
Leslie 2014 [47]rNRS; Uni; USAEX: 64 (23/41)
NEX: 90 (42/48)
EX/NEX: NR (NR-18.0)---4x PMsFA0.4 mm
Mladenovic 2024coll [54, 55]rNRS; Pract; AUSEX: 54 (18/36)
NEX: 59 (24/35)
EX/NEX: 15.0 (NR)CrowdingSkeletal Cl. I-II; any crowding; no craniofacial deformities-2x MX or 4 × 2nd PMsFA0.3 mm
Mostanghi 2021 [52]rNRS; Pract; USAEX: 20 (7/13)
NEX: 20 (5/15)
EX: 24.9 (18.5–38.3)
NEX: 26.2 (16.0–42.6)
Age; sex; treatment durationCrowding or bimaxillary dentoalveolar protrusion; no impactionsNo reported obstructive sleep apnea2x MX or 4x PMsFA0.3 mm
Pliska 2016 [48]rNRS; Uni; USAEX: 26 (8/18)
NEX: 48 (17/31)
EX: 27.4 (18.0-NR)
NEX: 31.9 (18.0-NR)
-Cl. I-II (ANB ≥ 0°); no agenesis-≥2x PMsFANR
Shannon 2012 [45]rNRS; Pract; USAEX: 27 (11/16)
NEX: 61 (30/31)
EX: 13.5 (9.0–22.0)
NEX: 13.2 (10.0–22.0)
-No agenesis; no craniofacial anomaly-4x PMsFANR
Stefanovic 2023 [46]rNRS; Uni; USAEX: 31 (15/16)
NEX: 31 (15/16)
EX: 13.0 (NR)
NEX: 12.9 (NR)
Age; sexCl. I-IIINo breathing disorder4 × 1st PMsFA0.38 mm
Valiathan 2010 [44]rNRS; Uni; USAEX: 20 (10/10)
NEX: 20 (10/10)
EX: 13.6 (11.3–15.6)
NEX: 13.7 (11.3–15.6)
Age,
gender, height, ethnicity, weight, BMI, and
skeletal features, and oropharynx volume
Cl. I; no craniofacial deformitiesNo pharyngeal
pathology and/or nasal obstruction, snoring, obstructive sleep apnea, adenoid- or tonsillectomy.
4x PMsFA0.38 mm
StudyDesign; country; settingPatients (M/F)Age*MatchingMalocclusion characteristicsBreathing/airways characteristicsExtractionAppliance; anchorageCBCT voxel size
Chen 2018 [49]rNRS; Uni; CHNEX: 25 (10/15)
NEX: 25 (10/15)
EX: 12.2 (NR)
NEX: 12.4 (NR)
-Dental Cl. I; no-mild crowding; ANB 0-4°; average angle/growth type; 1s-SN > 110°; 1i-ML > 99°No snoring/obstructive sleep apnea/adenoid-/tonsillectomy; normal BMI4 × 1st PMsFA; headgearNR
Feizi 2021 [51]rNRS; Pract; USAEX: 9 (4/5)
NEX: 18 (8/10)
EX: 19.2 (11.0–46.0)
NEX: 13.1 (11.0–17.0)
-Dental Class II (≥ 1/2 cusp); no agenesis (excluding M2/M3); no craniofacial anomaly-4x PMsFA0.3 mm
Guo 2022 [53]rNRS; Uni; CHNEX: 120 (0/120)
NEX: 40 (0/40)
EX: 25.1 (20.0–25.0)
NEX: 26.4 (20.0–25.0)
Age; skeletal typeSkeletal Class I-II/1 (ANB > 0°, SN-ML > 28°); no Cl. II/2; mild-moderate crowdingBMI < 27 kg/m2; no breathing disorder4 × 1st PMsFA; MX anterior retraction
≥3 mm
0.3 mm
Joy 2020 [50]rNRS; Uni; USAEX: 41 (20/21)
NEX: 42 (22/20)
EX: 26.1 (18.0-NR)
NEX: 26.0 (18.0-NR)
Age; sexCl. I-III; any crowding-2x MX or 4x PMsFA/AL;0.3 mm
Leslie 2014 [47]rNRS; Uni; USAEX: 64 (23/41)
NEX: 90 (42/48)
EX/NEX: NR (NR-18.0)---4x PMsFA0.4 mm
Mladenovic 2024coll [54, 55]rNRS; Pract; AUSEX: 54 (18/36)
NEX: 59 (24/35)
EX/NEX: 15.0 (NR)CrowdingSkeletal Cl. I-II; any crowding; no craniofacial deformities-2x MX or 4 × 2nd PMsFA0.3 mm
Mostanghi 2021 [52]rNRS; Pract; USAEX: 20 (7/13)
NEX: 20 (5/15)
EX: 24.9 (18.5–38.3)
NEX: 26.2 (16.0–42.6)
Age; sex; treatment durationCrowding or bimaxillary dentoalveolar protrusion; no impactionsNo reported obstructive sleep apnea2x MX or 4x PMsFA0.3 mm
Pliska 2016 [48]rNRS; Uni; USAEX: 26 (8/18)
NEX: 48 (17/31)
EX: 27.4 (18.0-NR)
NEX: 31.9 (18.0-NR)
-Cl. I-II (ANB ≥ 0°); no agenesis-≥2x PMsFANR
Shannon 2012 [45]rNRS; Pract; USAEX: 27 (11/16)
NEX: 61 (30/31)
EX: 13.5 (9.0–22.0)
NEX: 13.2 (10.0–22.0)
-No agenesis; no craniofacial anomaly-4x PMsFANR
Stefanovic 2023 [46]rNRS; Uni; USAEX: 31 (15/16)
NEX: 31 (15/16)
EX: 13.0 (NR)
NEX: 12.9 (NR)
Age; sexCl. I-IIINo breathing disorder4 × 1st PMsFA0.38 mm
Valiathan 2010 [44]rNRS; Uni; USAEX: 20 (10/10)
NEX: 20 (10/10)
EX: 13.6 (11.3–15.6)
NEX: 13.7 (11.3–15.6)
Age,
gender, height, ethnicity, weight, BMI, and
skeletal features, and oropharynx volume
Cl. I; no craniofacial deformitiesNo pharyngeal
pathology and/or nasal obstruction, snoring, obstructive sleep apnea, adenoid- or tonsillectomy.
4x PMsFA0.38 mm

AL, aligner; BMI, body mass index; CBCT, cone-bean computerized tomography; Cl., Angle’s Class; coll, collated multiple reports; CVM, cervical vertebrae maturation; EX, extraction group; FA, fixed appliance; M2/M3, 2nd/3rd molar; MX, maxillary; NEX, non-extraction group; NR, not reported; PM, premolar; Pract, private practice; rNRS, retrospective non-randomized study.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close